The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry

Zanfina Ademi, Molla MD Rashidul Huq, Danny Liew, Gabriel P Steg, Deepak L Bhatt, Mark Nelson, Christopher Michael Reid

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)


The aim of the study is to determine the extent of lost therapeutic benefit (LTB) in the hypertensive patients, and to determine the relationship between the presence of LTB and clinical outcomes. Methods: Prospective-cohort study of n = 2856 patients with or at high risk of atherothrombosis. LTB was calculated as the proportion of patients receiving blood pressure medication who were not attaining guideline blood pressure (BP) control targets (65 years (OR = 1.36 [1.06?1.75]) and having an ABI <0.09 in either leg at rest (OR = 1.30 [1.02?1.75]). Following PSM, the combination of ischemic events (55?64 age category) was more likely to occur in the LTB compared with non-LTB group (4.38 and 0.68 , respectively [P = 0.046]). Conclusion: Presence of HF, previous MI and being male decreased the likelihood of LTB, while presence of diabetes, age > 65 and ABI <0.09 increased the risk of LTB. Patients with LTB in age category 55?64 had higher incidence of vascular events compared with those with non-LTB.
Original languageEnglish
Pages (from-to)370 - 376
Number of pages7
JournalCardiovascular Therapeutics
Issue number6
Publication statusPublished - 2013

Cite this